INNV INNOVAGE HOLDING CORP
Health Care · Russell 2000
Next earnings: Tue 2 Feb 2027 · estimated
What 5 analyst firms say about INNOVAGE HOLDING CORP: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
4 rated views · 5 analyst/firm records · 5 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 5 reports on INNV from 3 analyst firms in the last 90 days (5 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target.
No firm's latest available rating differs from its previous one.
Latest observed target change: Keybanc raised its target from $13.00 (set 21 Aug 2026) to $14.00 on 9 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| JPMorgan | Benjamin Rossi | Sell | 23 Feb 2026 | 7.00 USD |
| KeyBanc Capital Markets | Matthew Gillmor | Buy | 9 Sep 2026 | 14.00 USD |
| Weiss Ratings | Unnamed analyst | — | 13 Aug 2026 | — |
| William Blair | Jared Haase | Hold | 9 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 24 Apr 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:07 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.